Lisdexamfetamine dimesylate Prescribing at MODALITY PARTNERSHIP (AWC)
CNS stimulants and drugs used for ADHD | Central Nervous System
Items (12m)
371
Total Quantity
11.1K
NHS Cost
£26.9K
vs National Avg
+210.7%
MODALITY PARTNERSHIP (AWC) prescribed 371 items of Lisdexamfetamine dimesylate over the last 12 months at a cost of £26,890 to the NHS. This is 210.7% above the national average prescribing rate. Lisdexamfetamine dimesylate is classified under CNS stimulants and drugs used for ADHD in the BNF.
Monthly Prescribing Trend
Jul 2026
32
Jul 2026
26
Jul 2026
25
Jul 2026
32
Jul 2026
24
Jul 2026
33
Jul 2026
33
Jul 2026
29
Jul 2026
33
Jul 2026
33
Jul 2026
40
Jul 2026
31
Prescribing Details
| Total Items | 371 |
|---|---|
| Total Quantity | 11,083 |
| Total NHS Cost | £26,890 |
| Presentations | 13 different forms |
| vs National Average | +210.7% |
Lisdexamfetamine dimesylate Prescribing Comparison
| This practice | 371 items |
|---|---|
| National average per practice | 119 items |
| Difference | +210.7% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.